Achillion Pharmaceuticals Inc. (ACHN) Stock Quote

Detailed Quote for Achillion Pharmaceuticals Inc. (ACHN)

After Hours: $ 10.06

0.165 (+1.67%)

Volume: 1.4 k

7:29 PM EST Feb 10, 2012

close 52 Week Information

52 Week High

January 13, 2012

Close: 12.95

52 Week Low

October 4, 2011

Close: 3.81

Today

Last Price
9.895

Change $
0.425

Change %
4.49%

Tick
N/A

Bid
N/A

Bid Size
0

Ask
N/A

Ask Size
0

Open
9.47

High
10.20

Low
9.319

Prev Close
9.47

Last Trade
2/10/12

Volume
1.51 m

52 Wk Hi
12.95

52 Wk Low
3.81

Market Cap
690.11 m

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
69,743,721

EPS (TTM)
-0.61

PE Ratio
N/A

close Exchange Information Listed On Nasdaq Global Select (NGS) Exchange
NGS

News and Media for Achillion Pharmaceuticals Inc. (ACHN)

Sector News | Topic News

News for ACHN

Wed, Feb 08, 2012

7:00 AM

Achillion to Present at Three Upcoming Investor Conferences - Globe Newswire

Mon, Feb 06, 2012

8:56 AM

Emerald Holds Annual Groundhog Day Investment Forum - Business Wire

Fri, Feb 03, 2012

7:00 AM

Achillion Announces Executive Promotion - Globe Newswire

Tue, Jan 24, 2012

4:56 AM

Achillion Shares Have Lost Nearly One Third of their Value Since Rocketing to 52-Wk Highs - Accesswire

4:56 AM

Achillion Shares Have Lost Nearly One Third of their Value Since Rocketing to 52-Wk Highs - Accesswire

Fri, Jan 13, 2012

4:05 PM

Achillion to Present at the Noble Financial Capital Markets' Eighth Annual Equity Conference - Globe Newswire

9:00 AM

A Forward Look, the Year Ahead -- Featured Research on Achillion Pharmaceuticals, Inc. and Nektar Therapeutics - Marketwire

Mon, Jan 09, 2012

7:00 AM

Achillion Reports Clinical Data on Portfolio of Protease Inhibitors - Globe Newswire

Wed, Jan 04, 2012

7:00 AM

ACH-1625 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C - Globe Newswire

Mon, Dec 05, 2011

7:00 AM

Achillion Announces Preliminary Phase 1b Proof-of-Concept Data With ACH-2928 NS5A Inhibitor for the Treatment of Hepatitis C - Globe Newswire

Mon, Nov 21, 2011

7:00 AM

Achillion to Present at the 23rd Annual Piper Jaffray Health Care Conference - Globe Newswire

Tue, Nov 08, 2011

7:00 AM

Achillion Reports Third Quarter and Nine Month 2011 Financial Results - Globe Newswire

Mon, Nov 07, 2011

9:00 AM

A Turn in Tide, Europe's New Deal - Research Report on Achillion Pharmaceuticals, Inc. and Idenix Pharmaceuticals, Inc. - Marketwire

Thu, Nov 03, 2011

7:00 AM

Achillion to Present at the Credit Suisse 2011 Healthcare Conference - Globe Newswire

Thu, Oct 13, 2011

7:00 AM

Achillion Announces Nomination of Second Generation NS5A Inhibitor for the Treatment of Hepatitis C - Globe Newswire

Mon, Oct 03, 2011

7:01 AM

Achillion to Present Updated Clinical and Preclinical Data on Multiple Compounds at AASLD 2011 - Globe Newswire

Thu, Sep 22, 2011

7:00 AM

Achillion to Present at the JMP Healthcare Conference - Globe Newswire

Tue, Sep 20, 2011

9:55 AM

Global Situation & Resulting Influences - Research Report on Achillion Pharmaceuticals, Inc. and Nektar Therapeutics - Marketwire

Wed, Aug 31, 2011

7:00 AM

Achillion to Present at Two Upcoming Investor Conferences - Globe Newswire

Tue, Jul 26, 2011

7:00 AM

Achillion Announces Executive Promotion - Globe Newswire

More News for ACHN >>

Tags for Achillion Pharmaceuticals Inc.